Established in 1996, Tatva Chintan Pharma Chem Ltd. is a leading chemical manufacturing company. Tatva Chintan Pharma products mostly include SDAs, PTCs, agrochemical intermediates, and other speciality chemicals.
Apart from India, its products are also available in 25+ nations, including the USA, Germany, China, and the UK. Tatva Chintan Pharma has two manufacturing units in Ankleshwar and Dahej of Gujarat.
The IPO of Tatva Chintan Pharma Chem Ltd. is all set to open on 16 July 2021. Here are some of the key objectives of the issue:
To know more about Tatva Chintan Pharma IPO, let’s take a detailed look at the following section:
The Tatva Chintan Pharma IPO date is 16 July 2021. This IPO will be closing on 20 July 2021. The basis of allotment and initiation of refunds will occur on the 26 and 27 July, respectively. The IPO listing is set for 29 July.
Investors interested in Tatva Chintan Pharma IPO can take a quick look at the financial overview of the company:
Period | Assets (Rs. in millions) | Revenue (Rs. in millions) | Profit (Rs. in millions) |
31 March 2021 | 3.148.30 | 3,062.92 | 522.62 |
31 March 2020 | 2498.38 | 2,646.22 | 377.89 |
31 March 2019 | 1,875.08 | 2,068.01 | 205.43 |
Tatva Chintan Pharma has the edge over its competitors in the following aspects:
Tatva Chintan Pharma Chem’s strong financials, diversified product offering, and global footprint make its IPO one of the top plays this season. The company is expected to realise sizeable growth in the still-unsaturated domestic and international markets with no significant peer.
For more important updates about the financial and stock market world, you can check out the Angel One blogs.
Tatva Chintan Pharma IPO will be listed on both NSE and BSE.
The lot size is 13 shares.
14 lots or 182 shares for Rs. 197106.
We're Live on WhatsApp! Join our channel for market insights & updates